Finley John Davidinsider trades
In SEC Form 4 filings, Finley John David is listed as CEO CFO of Palisade Bio, Inc. (PALI). Finley John David reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 7.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PALIPalisade Bio, Inc. | CEO CFO | 6 | Oct 7 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PALIPalisade Bio, Inc. | Oct 6 | Oct 7 | M | 3,227,384 | not reported | not reported | 3,356,672 | No | Form 4 |
| PALIPalisade Bio, Inc. | Oct 6 | Oct 7 | F | 1,411,982 | $1.49 | $2,103,853 | 1,944,690 | No | Form 4 |
| PALIPalisade Bio, Inc. | Oct 6 | Oct 7 | M · derivative | 3,059,800 | $0.00 | $0 | 6,119,600 | No | Form 4 |
| PALIPalisade Bio, Inc. | Oct 6 | Oct 7 | M · derivative | 167,584 | $0.00 | $0 | 1,508,249 | No | Form 4 |
| PALIPalisade Bio, Inc. | Aug 19 | Aug 21 | G | 88,400 | $0.00 | $0 | 129,288 | No | Form 4 |
| PALIPalisade Bio, Inc. | Aug 19 | Aug 21 | G | 88,400 | $0.00 | $0 | 88,451 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.